These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

290 related articles for article (PubMed ID: 11594239)

  • 1. Pioglitazone: mechanism of action.
    Smith U
    Int J Clin Pract Suppl; 2001 Sep; (121):13-8. PubMed ID: 11594239
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Current treatment of insulin resistance in type 2 diabetes mellitus.
    Tan MH
    Int J Clin Pract Suppl; 2000 Oct; (113):54-62. PubMed ID: 11965833
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Activation of human peroxisome proliferator-activated receptor (PPAR) subtypes by pioglitazone.
    Sakamoto J; Kimura H; Moriyama S; Odaka H; Momose Y; Sugiyama Y; Sawada H
    Biochem Biophys Res Commun; 2000 Nov; 278(3):704-11. PubMed ID: 11095972
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Mechanisms of action of thiazolidinediones].
    Girard J
    Diabetes Metab; 2001 Apr; 27(2 Pt 2):271-8. PubMed ID: 11452221
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mechanism by which a novel non-thiazolidinedione peroxisome proliferator-activated receptor gamma agonist, FK614, ameliorates insulin resistance in Zucker fatty rats.
    Minoura H; Takeshita S; Kimura C; Hirosumi J; Takakura S; Kawamura I; Seki J; Manda T; Mutoh S
    Diabetes Obes Metab; 2007 May; 9(3):369-78. PubMed ID: 17391165
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pioglitazone: beyond glucose control.
    de Pablos-Velasco P
    Expert Rev Cardiovasc Ther; 2010 Aug; 8(8):1057-67. PubMed ID: 20670183
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of pioglitazone on glucose and lipid metabolism in Wistar fatty rats.
    Sugiyama Y; Taketomi S; Shimura Y; Ikeda H; Fujita T
    Arzneimittelforschung; 1990 Mar; 40(3):263-7. PubMed ID: 2189419
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pioglitazone can ameliorate insulin resistance in low-dose streptozotocin and high sucrose-fat diet induced obese rats.
    Ding SY; Shen ZF; Chen YT; Sun SJ; Liu Q; Xie MZ
    Acta Pharmacol Sin; 2005 May; 26(5):575-80. PubMed ID: 15842776
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pioglitazone, a specific ligand of the peroxisome proliferator-activated receptor gamma reduces gastric mucosal injury induced by ischaemia/ reperfusion in rat.
    Konturek PC; Brzozowski T; Kania J; Kukharsky V; Bazela K; Kwiecien S; Harsch I; Konturek SJ; Hahn EG
    Scand J Gastroenterol; 2003 May; 38(5):468-76. PubMed ID: 12795455
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pioglitazone ameliorates tumor necrosis factor-alpha-induced insulin resistance by a mechanism independent of adipogenic activity of peroxisome proliferator--activated receptor-gamma.
    Iwata M; Haruta T; Usui I; Takata Y; Takano A; Uno T; Kawahara J; Ueno E; Sasaoka T; Ishibashi O; Kobayashi M
    Diabetes; 2001 May; 50(5):1083-92. PubMed ID: 11334412
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prevention of ethanol-induced liver injury in rats by an agonist of peroxisome proliferator-activated receptor-gamma, pioglitazone.
    Enomoto N; Takei Y; Hirose M; Konno A; Shibuya T; Matsuyama S; Suzuki S; Kitamura KI; Sato N
    J Pharmacol Exp Ther; 2003 Sep; 306(3):846-54. PubMed ID: 12805475
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pioglitazone attenuates diabetic nephropathy through an anti-inflammatory mechanism in type 2 diabetic rats.
    Ko GJ; Kang YS; Han SY; Lee MH; Song HK; Han KH; Kim HK; Han JY; Cha DR
    Nephrol Dial Transplant; 2008 Sep; 23(9):2750-60. PubMed ID: 18388116
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A novel insulin sensitizer acts as a coligand for peroxisome proliferator-activated receptor-alpha (PPAR-alpha) and PPAR-gamma: effect of PPAR-alpha activation on abnormal lipid metabolism in liver of Zucker fatty rats.
    Murakami K; Tobe K; Ide T; Mochizuki T; Ohashi M; Akanuma Y; Yazaki Y; Kadowaki T
    Diabetes; 1998 Dec; 47(12):1841-7. PubMed ID: 9836514
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Thiazolidinediones--tools for the research of metabolic syndrome X.
    Komers R; Vrána A
    Physiol Res; 1998; 47(4):215-25. PubMed ID: 9803467
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Role of PPARg2 transcription factor in thiazolidinedione-induced insulin sensitization.
    Saraf N; Sharma PK; Mondal SC; Garg VK; Singh AK
    J Pharm Pharmacol; 2012 Feb; 64(2):161-71. PubMed ID: 22221092
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Muraglitazar, a novel dual (alpha/gamma) peroxisome proliferator-activated receptor activator, improves diabetes and other metabolic abnormalities and preserves beta-cell function in db/db mice.
    Harrity T; Farrelly D; Tieman A; Chu C; Kunselman L; Gu L; Ponticiello R; Cap M; Qu F; Shao C; Wang W; Zhang H; Fenderson W; Chen S; Devasthale P; Jeon Y; Seethala R; Yang WP; Ren J; Zhou M; Ryono D; Biller S; Mookhtiar KA; Wetterau J; Gregg R; Cheng PT; Hariharan N
    Diabetes; 2006 Jan; 55(1):240-8. PubMed ID: 16380499
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Metabolic and additional vascular effects of thiazolidinediones.
    Martens FM; Visseren FL; Lemay J; de Koning EJ; Rabelink TJ
    Drugs; 2002; 62(10):1463-80. PubMed ID: 12093315
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Protective effects of preischemic treatment with pioglitazone, a peroxisome proliferator-activated receptor-gamma ligand, on lung ischemia-reperfusion injury in rats.
    Ito K; Shimada J; Kato D; Toda S; Takagi T; Naito Y; Yoshikawa T; Kitamura N
    Eur J Cardiothorac Surg; 2004 Apr; 25(4):530-6. PubMed ID: 15037267
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Berberine improves free-fatty-acid-induced insulin resistance in L6 myotubes through inhibiting peroxisome proliferator-activated receptor gamma and fatty acid transferase expressions.
    Chen Y; Li Y; Wang Y; Wen Y; Sun C
    Metabolism; 2009 Dec; 58(12):1694-702. PubMed ID: 19767038
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hypoglycemic action of thiazolidinediones/peroxisome proliferator-activated receptor gamma by inhibition of the c-Jun NH2-terminal kinase pathway.
    Díaz-Delfín J; Morales M; Caelles C
    Diabetes; 2007 Jul; 56(7):1865-71. PubMed ID: 17416798
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.